BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 6365507)

  • 1. Ursodeoxycholic acid: a review of its pharmacological properties and therapeutic efficacy.
    Ward A; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1984 Feb; 27(2):95-131. PubMed ID: 6365507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative efficacy and side effects of ursodeoxycholic and chenodeoxycholic acids in dissolving gallstones. A double-blind controlled study.
    Fromm H; Roat JW; Gonzalez V; Sarva RP; Farivar S
    Gastroenterology; 1983 Dec; 85(6):1257-64. PubMed ID: 6354826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differing effects of ursodeoxycholic or chenodeoxycholic acid on biliary cholesterol saturation and bile acid metabolism in man. A dose-response study.
    Thistle JL; Larusso NF; Hofmann AF; Turcotte J; Carlson GL; Ott BJ
    Dig Dis Sci; 1982 Feb; 27(2):161-8. PubMed ID: 7075411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gallstone dissolution treatment with a combination of chenodeoxycholic and ursodeoxycholic acids. Studies of safety, efficacy and effects on bile lithogenicity, bile acid pool, and serum lipids.
    Roehrkasse R; Fromm H; Malavolti M; Tunuguntla AK; Ceryak S
    Dig Dis Sci; 1986 Oct; 31(10):1032-40. PubMed ID: 3757719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of litholytic bile acids on cholesterol absorption in gallstone patients.
    LaRusso NF; Thistle JL
    Gastroenterology; 1983 Feb; 84(2):265-71. PubMed ID: 6848406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ursodeoxycholic acid: a safe and effective agent for dissolving cholesterol gallstones.
    Tint GS; Salen G; Colalillo A; Graber D; Verga D; Speck J; Shefer S
    Ann Intern Med; 1982 Sep; 97(3):351-6. PubMed ID: 7051912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of response to ursodeoxycholic acid for gallstone dissolution.
    Bateson MC; Hill A; Bouchier IA
    Digestion; 1980; 20(5):358-64. PubMed ID: 7390061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of a combination of chenodeoxycholic acid and ursodeoxycholic acid for gallstone dissolution: a comparison with ursodeoxycholic acid alone.
    Podda M; Zuin M; Battezzati PM; Ghezzi C; de Fazio C; Dioguardi ML
    Gastroenterology; 1989 Jan; 96(1):222-9. PubMed ID: 2642440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes of bile acid and lipid composition in blood and bile in the clinical course after the initiation of cheno- and ursodeoxycholic acid therapy in patients with cholesterol gallstones.
    Iwamura K
    Tokai J Exp Clin Med; 1982 Nov; 7(6):671-83. PubMed ID: 7184199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of cholesterol gallstone dissolution by glycocheno-, glyco-ursodeoxycholic acid, and mixtures of both in vitro.
    Raedsch R; Stiehl A; Götz R; Walker S; Kommerell B
    Z Gastroenterol; 1981 Apr; 19(4):159-63. PubMed ID: 7234028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose ursodeoxycholic acid prolongs cholesterol nucleation time in gallbladder bile of patients with cholesterol gallstones.
    Jüngst D; Brenner G; Pratschke E; Paumgartner G
    J Hepatol; 1989 Jan; 8(1):1-6. PubMed ID: 2921499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral dissolution therapy for cholelithiasis: mix and match.
    Phillips RS; Barkin JS
    Am J Gastroenterol; 1990 Nov; 85(11):1532-3. PubMed ID: 2239886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ursodeoxycholic acid in the treatment of gallbladder lithiasis].
    Mamianetti A; Labonia NA; Lafont D; Fiordalisi HH
    Acta Gastroenterol Latinoam; 1982; 12(1):33-8. PubMed ID: 7136453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ursodeoxycholic acid alone or with chenodeoxycholic acid for dissolution of cholesterol gallstones: a randomized multicentre trial. The British-Italian Gallstone Study group.
    Petroni ML; Jazrawi RP; Pazzi P; Lanzini A; Zuin M; Pigozzi MG; Fracchia M; Galatola G; Alvisi V; Heaton KW; Podda M; Northfield TC
    Aliment Pharmacol Ther; 2001 Jan; 15(1):123-8. PubMed ID: 11136285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical studies on cheno- and ursodeoxycholic acid treatment for gallstone dissolution.
    Iwamura K
    Hepatogastroenterology; 1980 Feb; 27(1):26-34. PubMed ID: 7203354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ursodeoxycholic acid treatment of gallstones.
    Thistle JL
    Semin Liver Dis; 1983 May; 3(2):146-56. PubMed ID: 6346500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical treatment of biliary duct stones: effect of ursodeoxycholic acid administration.
    Salvioli G; Salati R; Lugli R; Zanni C
    Gut; 1983 Jul; 24(7):609-14. PubMed ID: 6345281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of biliary bile acid composition on biliary cholesterol saturation in gallstone patients treated with chenodeoxycholic acid and/or ursodeoxycholic acid.
    Stiehl A; Raedsch R; Czygan P; Götz R; Männer C; Walker S; Kommerell B
    Gastroenterology; 1980 Dec; 79(6):1192-8. PubMed ID: 7439628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical perspective on the treatment of gallstones with ursodeoxycholic acid.
    Salen G
    J Clin Gastroenterol; 1988; 10 Suppl 2():S12-7. PubMed ID: 3062079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biliary lipid metabolism in gallstone disease and during gallstone dissolution treatment.
    Nilsell K
    Acta Chir Scand Suppl; 1985; 528():1-38. PubMed ID: 3866449
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.